Clairvoyant Therapeutics

About:

Clairvoyant Therapeutics is a biotechnology company changing the face of psychedelic therapy with a speed-to-market clinical strategy.

Website: https://www.clairvoyantrx.com/

Twitter/X: clairvoyantrx

Top Investors: Negev Capital, Origin Therapeutics

Description:

Clairvoyant Therapeutics is a biotechnology company changing the face of psychedelic therapy with a speed-to-market clinical strategy.

Total Funding Amount:

2.35M CAD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2021-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-07-07

IPO Status:

Private

Industries: